Coherus Oncology, Inc.CHRSNASDAQ
LOADING
|||
EBITDA Over Time
Trending higher, above historical average.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$60.94M
↑ 153% above average
Average (9y)
$-114.50M
Historical baseline
Range
High:$161.84M
Low:$-260.69M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $60.94M | +131.4% |
| 2023 | $-193.94M | +24.1% |
| 2022 | $-255.58M | +2.0% |
| 2021 | $-260.69M | -261.1% |
| 2020 | $161.84M | +45.8% |
| 2019 | $111.03M | +154.3% |
| 2018 | $-204.42M | +9.3% |
| 2017 | $-225.34M | -92.9% |
| 2016 | $-116.81M | +47.4% |
| 2015 | $-222.04M | - |